🇺🇸·2h agoCRO
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
Publisher
L
Labcorp Drug Development
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Labcorp Drug Development
- Region
- USA
- Scope
- CRO
- Published
- June 22, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.labcorp.com
Leave the platform to read the original full article on the publisher site.
Source: Labcorp Drug Development
Scope: CRO
Related coverage
More related coverage
Greenlight Guru Blog/2h ago
Using AI to close the post-market design loop | Greenlight Guru
Hôpitaux Universitaires de Strasbourg/2h ago
Les Hôpitaux Universitaires de Strasbourg remportent le Challenge des Foulées éco-solidaires pour la deuxième année consécutive
Hôpitaux Universitaires de Strasbourg/2h ago
Les HUS informent et accompagnent les patients atteints d’un cancer du rein
AbbVie News/2h ago